Drugs to awaken a paternal gene

Arthur L. Beaudet ()
Additional contact information
Arthur L. Beaudet: Baylor College of Medicine, Houston, Texas 77030, USA.

Nature, 2012, vol. 481, issue 7380, 151-152

Abstract: Mutations in the maternal copy of the UBE3A gene cause a neurodevelopmental disorder known as Angelman syndrome. Drugs that activate the normally silenced paternal copy of this gene may be of therapeutic value. See Letter p.185

Date: 2012
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/nature10784 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:481:y:2012:i:7380:d:10.1038_nature10784

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/nature10784

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().